Shailja Dixit

Shailja Dixit has extensive work experience in various roles within the healthcare industry. Shailja is currently the CEO of Curio Digital Therapeutics Inc. Prior to this, they served as the CEO of Apexhealth LLC and also held the position of Venture Partner at FundRx. Shailja has been a Member of the Board at CLIRNet Services Pvt. Ltd. Since 2018, they have been the Chair of Faculty at Rutgers University. In 2017, they worked as the Chief Medical Officer and Head of Global Innovation at Sutherland Health Solutions. Shailja Dixit has also held positions at Intercept Pharmaceuticals and Allergan, where they gained experience in health outcomes research and field managed care science liaison. Shailja began their career at Accenture as a Healthcare Executive, specializing in healthcare IT and management consultancy.

Shailja Dixit's education history begins with their time at Kendriya Vidyalaya, although specific start and end years are not provided. Moving forward, they attended Uttar Pradesh Jobs from 1993 to 1999, where they pursued an MD degree in Surgery/Medicine. Shailja then went on to the University of Medicine and Dentistry of New Jersey and obtained an MS degree in Medical Informatics, studying from 2000 to 2002. Lastly, Shailja attended Columbia University from 2003 to 2005, where they pursued an MPH/MBA degree, without mentioning a specific field of study.